10x Genomics, Inc.
A life-sciences technology company that makes instruments, consumables, and software for studying biology at the level of individual cells and their spatial context, using its Chromium and Visium platforms. Founded in 2012 in Pleasanton, California, by Serge Saxonov, Ben Hindson, and Kevin Ness, the company's name reflects their goal of a ten-fold, or "10x," improvement in biological resolution rather than incremental progress.
Granted 207.9K · Sold 136.5K
Granted 88.8K · Sold 41.5K
Granted 8.8K
Granted 106.6K · Sold 53.1K
Granted 8.8K
Granted 8.8K
Granted 8.8K
Granted 8.8K · Sold 7.6K
Granted 8.8K · Sold 7.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Saxonov SergeChief Executive Officer, Director · 19 transactions | — | 4.40M | 207.9K | — | 136.5K |
| Hindson Benjamin J.See Remarks, Director · 5 transactions | +10.7% | 488.2K | 88.8K | — | 41.5K |
| Stuelpnagel John RDirector · 1 transaction | +2.5% | 368.4K | 8.8K | — | — |
| Taich AdamChief Financial Officer · 5 transactions | +17.3% | 362.7K | 106.6K | — | 53.1K |
| Mateo AlanDirector · 1 transaction | +11.5% | 85.9K | 8.8K | — | — |
| Kosaraju SridharDirector · 1 transaction | +14.9% | 68.3K | 8.8K | — | — |
| Popovits Kimberly JDirector · 1 transaction | +30.9% | 37.4K | 8.8K | — | — |
| Teichmann Sarah A.Director · 2 transactions | +3.6% | 35.6K | 8.8K | — | 7.6K |
| Suliman ShehnaazDirector · 5 transactions | +3.1% | 29.5K | 8.8K | — | 7.9K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -246.6K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.